biospecimen__admin__batch_number	303.59.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	F5936985-D6B8-4185-B84E-FD0F560D8D09
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-HP-A5N0-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-HP-A5N0-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-HP-A5N0-01A
biospecimen__bio__biospecimen_barcode_bottom	0132269150
biospecimen__bio__day_of_creation	02
biospecimen__bio__day_of_shipment	30
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-HP-A5N0.0221A6F3-34F5-407E-8548-B62F27F66FCE.pdf
biospecimen__bio__plate_column	12
biospecimen__bio__plate_id	A28Z
biospecimen__bio__plate_row	A
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-HP-A5N0
biospecimen__shared__patient_id	A5N0
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	40E58611-CD92-4923-A677-E75B388E1C75
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	2.6
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__creatinine_lower_level	0
clinical__chol_lihc_shared__creatinine_upper_limit	0.9
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.5
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__prothrombin_time_result_value	1.2
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__clin_shared__age_at_initial_pathologic_diagnosis	90
clinical__clin_shared__bcr_followup_barcode	TCGA-HP-A5N0-F70727
clinical__clin_shared__bcr_followup_uuid	5BF63BAF-32F5-472F-8435-8889581D9286
clinical__clin_shared__cancer_first_degree_relative	3
clinical__clin_shared__day_of_form_completion	30
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	5
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2015
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	185
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	TX
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	1e9b031c-e1b6-4cda-8565-cfeadf6826c8
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-HP-A5N0-01A-11R-A28Z-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	f41f3a28-02f1-46dc-9d2b-d5b5cefb8b7d
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.9
gdc__analytes__analyte_id	fe1c7f61-4ee5-4145-8cb6-a5a3ce128ec2
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	7f8e25d4-6021-4327-96ab-79b6fcc97a24
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:37:39.749293-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	66bfa9c1-e989-598f-b521-19ed3bba92ac
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	female
gdc__demographic__race	not reported
gdc__diagnoses__age_at_diagnosis	32120
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-32120.0
gdc__diagnoses__days_to_death	1147.0
gdc__diagnoses__diagnosis_id	a7736b14-a845-59ab-9213-c36310a3486d
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8174/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma clear cell type
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	not reported
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	26.709401709401707
gdc__exposures__exposure_id	dba7685a-48ab-5f98-800f-c9acae11e60a
gdc__exposures__height	156.0
gdc__exposures__weight	65.0
gdc__file_id	1d6cd5e0-ab0a-4f1d-ad72-31408589e553
gdc__file_name	191bae10-9f2a-40ef-aed7-349901cb9097.mirbase21.mirnas.quantification.txt
gdc__file_size	50325
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	db696dbf807f66dca095d56240183ab6
gdc__portions__is_ffpe	false
gdc__portions__portion_id	463725da-64e3-4bcb-bc2f-c146179c3c41
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__initial_weight	350.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	0221A6F3-34F5-407E-8548-B62F27F66FCE
gdc__samples__sample_id	26dc1e14-4925-4258-8e46-1d52dfdd1b4f
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	9363d006-8fa3-42f9-836f-e5e83c5f8da1
gdc__submitter_id	mirna_swap_dr11_247_MirnaExpressionfb683797-e085-41da-8776-8e05a6eb1657_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	HP
gdc__tissue_source_site__name	Ontario Institute for Cancer Research (OICR)
gdc__tissue_source_site__tissue_source_site_id	b521e8d8-2b93-5a14-9fd0-ece883fd1327
gdc__treatments__treatment_id	fc85888f-381c-55fd-954b-bbbad6f9b85e
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:07:22.242+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/1e9b031c-e1b6-4cda-8565-cfeadf6826c8-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/1e9b031c-e1b6-4cda-8565-cfeadf6826c8-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129696
manually_curated__local_md5	9478f770774c42df85de19aabf050bd6
manually_curated__opengdc_download_date	2018-10-16T17:10:57.000624+02:00
manually_curated__opengdc_file_md5	cb76c1a0e20ce3af2a7c835c21098be0
manually_curated__opengdc_file_size	50324
manually_curated__opengdc_id	1e9b031c-e1b6-4cda-8565-cfeadf6826c8-meq
manually_curated__origin_file_size	129696
manually_curated__origin_last_modified_date	Tue Oct 16 17:54:00 CEST 2018
manually_curated__origin_md5	9478f770774c42df85de19aabf050bd6
manually_curated__tissue_status	tumoral
